Stocks
ResMed (RMD) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2023 | FY2024 | FY2025 | FY2026 | FY2026 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 24.6 | 0.41 | 19.6 | 12.8 | 12.8 | 12.8 | ||
| Changes by years, y/y, % | -7% | -98% | +4 628% | -34% | 0% | -17.2% | |||
ResMed. EV/EBITDA
ResMed. EV/EBITDA, changes, %
ResMed (RMD) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2026Q2 | FY2026Q3 | FY2026Q3 | FY2026Q4 | FY2026Q4 | LTM ? | |||
| EV/EBITDA | ? | 16.8 | 14.7 | 14.7 | 12.8 | 12.8 | 12.8 | |
| Changes by years, y/y, % | -15% | -21% | -21% | -34% | -34% | |||
| Changes by quarters, q/q, % | -16% | -13% | 0% | -12% | 0% | |||
